Moro Orange Extract (Morosil)
Also called Morosil, Moro blood orange extract, blood orange extract, red orange juice extract, Citrus sinensis 'Moro', Sicilian blood orange extract.
Best grade C across 2 graded outcomes Botanical Last checked
The short answer
From 3 sourcesMoro orange extract, sold mainly as Morosil, is a blood-orange juice extract marketed for weight management. A 2026 meta-analysis of three randomized trials (252 adults) found about 2 kg more weight loss than placebo. The largest trial, funded by the extract's maker, used 400 mg a day alongside a calorie-controlled diet and exercise for 6 months.
Every graded outcome on this page
2 rows · line = participantsKey facts
- Weight
- Pooled across 3 randomized trials (252 overweight adults), body weight fell 2.08 kg more than placebo and fat mass 1.53 kg more3
- Six-month trial
- With 400 mg/day plus diet and exercise, weight fell 4.2% vs 2.2% on placebo over 6 months1
- Funding
- The 6-month trial was funded by Bionap, the company that supplied the Morosil extract, which also paid the article's publication charge1
- What's in it
- The trial extract contained about 0.6% cyanidin-3-glucoside, 2.1% hesperidin and 4.5% vitamin C by weight1
- Lean mass
- No significant effect on lean mass in the pooled analysis3
What it is
Moro orange extract is a dried, standardized extract of juice from the Moro blood orange, a Sicilian cultivar rich in anthocyanins.
How it works
ProposedThe extract combines anthocyanins (mainly cyanidin-3-glucoside), flavanones such as hesperidin, hydroxycinnamic acids and vitamin C. Researchers propose that these act together on fat storage and inflammation, based mainly on cell and animal studies; how the extract works in people has not been established.12
Forms
Form
| Form | Elemental % | Absorption (human data) | GI tolerance | Studied for |
|---|---|---|---|---|
| Standardized Moro orange juice extract (Morosil) | Varies1Not applicable (whole compound or extract; no elemental fraction) | No human absorption data for the extract in our sources.1 | Liver safety markers stayed in the normal range over 6 months; adverse symptoms, mostly digestive such as nausea or constipation, were reported by 2 people on the extract and 5 on placebo.1 | Weight and body fat |
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
2 graded outcomes, largest study firstAll 2 graded outcomes found an improvement. The largest, a 2026 meta-analysis of 252 people on body weight and fat mass, found an improvement.
1Body weight and fat mass
Improved · Grade C · Meta-analysis, 252 people, 2026
Overweight and obese adults in randomized placebo-controlled trials
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Body weight and fat mass | Improved | 252 | Grade C · Meta-analysis, 2026 | Overweight and obese adults in randomized placebo-controlled trials |
| Weight, waist and body fat over 6 months | Improved | 136 | Grade C · RCT, 2022 | Overweight but otherwise healthy adults aged 20-65 on a calorie-controlled diet and exercise (Australia) |
Every graded row
2 rowsCGrade CBody weight and fat massWeight−2.08 kg vs placeboMeta-analysis · 3 studies
n 252 · 2026
Improved Body weight fell 2.08 kg more than placebo (95% CI -3.50 to -0.67; I² = 0%) and fat mass 1.53 kg more (95% CI -2.92 to -0.15); waist results were highly heterogeneous (I² = 99%); no significant effect on lean mass.
- Design
- Meta-analysis, 3 studies, n = 252, 2026
- Population
- Overweight and obese adults in randomized placebo-controlled trials
- Form
- Moro orange juice extract vs placebo
- Dose
- 400 mg/day of Morosil in two trials; the third (Kegele 2019) tested a different sweet-orange extract, CitrusiM
- Duration
- 3 to 6 months across the three trials
- Source
- Reference 3 · PubMed 40956687 (opens PubMed)
CGrade CWeight, waist and body fat over 6 monthsWeight−4.2% vs −2.2% body weightRCT
n 136 · 2022
Improved Body weight fell 4.2% vs 2.2% (p = 0.015); waist fell 3.9 vs 1.7 cm (p = 0.017); fat mass and visceral fat also improved vs placebo. Liver safety markers stayed normal.
- Design
- RCT, n = 136, 2022
- Population
- Overweight but otherwise healthy adults aged 20-65 on a calorie-controlled diet and exercise (Australia)
- Form
- Morosil standardized Moro orange extract vs maltodextrin placebo
- Dose
- 400 mg/day
- Duration
- 6 months
- Source
- Reference 1 · PubMed 35276783 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Moro Orange Extract and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Moro Orange Extract.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- Pregnancy and breastfeeding
- Pregnant and breastfeeding women were excluded from the 6-month trial, so there are no safety data for them.1
- People with medical conditions
- The trials enrolled overweight but otherwise healthy adults. People with uncontrolled cardiovascular, kidney, endocrine, psychiatric and other significant conditions were excluded.1
- Drug interactions
- No published human drug-interaction studies were found. The 6-month trial excluded people using prescription medicines other than the contraceptive pill, so use alongside medicines, including blood thinners, is untested.13
- People on blood thinners
- Use with blood thinners such as warfarin is untested: the 6-month trial excluded people taking prescription medicines other than the contraceptive pill.1
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksLook for the standardized extract
Diet still matters
In the 6-month trial both groups lost weight on a calorie target and exercise; the extract added about 2 percentage points.1
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
6 answersDoes Moro orange extract help with weight loss?
Is Moro orange extract safe?
In the 6-month trial liver safety markers stayed normal and side effects were rare. Long-term data and data in pregnancy are lacking.1
How much was studied, and how fast did it work?
Does Moro orange extract interact with medicines?
Is it the same as bitter orange?
No. Moro is a blood orange cultivar of the sweet orange, Citrus sinensis; bitter orange is a different citrus species with its own page and safety profile.1
Sources
3 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
3 sources- 1Effectiveness of "Moro" Blood Orange Citrus sinensis Osbeck (Rutaceae) Standardized Extract on Weight Loss in Overweight but Otherwise Healthy Men and Women-A Randomized Double-Blind Placebo-Controlled Study.RCT Nutrients, 2022 · PMID 35276783
- 2Clinical evaluation of Moro (Citrus sinensis (L.) Osbeck) orange juice supplementation for the weight management.RCT Nat Prod Res, 2015 · PMID 25588369
- 3Effect of Moro orange juice extract supplementation in weight management in adults: A systematic review and meta-analysis.Meta-analysis Nutr Health, 2026 · PMID 40956687
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| FAQ | Added 2 FAQs (studied dose and timing from PMID 25588369 and 35276783; untested drug interactions). PubMed searches for newer Moro orange, Morosil or blood orange extract RCTs or meta-analyses (2023–2026) found none beyond the 2026 meta-analysis already cited; Cardile 2015 (PMID 25588369) was not given its own evidence row because its abstract does not report the number of participants. No published interactions were found, so the interactions list stays empty with the existing safety notes. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice. | Writer: Kymata Health EditorialTrigger: new page |
| forms, key facts, evidence, who should avoid, FAQ, insights | Review fixes: adverse symptoms corrected to 2 on extract vs 5 on placebo (results section of PMID 35276783); Bionap paid the publication charge; 98 completed against the 120 needed for power; the meta-analysis pooled 3 trials including Kegele 2019 (CitrusiM), replacing 'both published trials'; blood thinners stated as untested because the trial excluded prescription medicines. | Writer: Kymata Health EditorialTrigger: adversarial review |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.